Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$1.08 - $1.83 $74 - $126
69 New
69 $1,000
Q4 2021

Feb 14, 2022

SELL
$2.72 - $5.72 $179 - $377
-66 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$4.83 - $7.2 $318 - $475
66 New
66 $1,000
Q2 2021

Aug 16, 2021

SELL
$2.32 - $5.38 $1,883 - $4,368
-812 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$2.24 - $4.25 $1,818 - $3,451
812 New
812 $2,000

Others Institutions Holding CLSD

About Clearside Biomedical, Inc.


  • Ticker CLSD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,190,700
  • Market Cap $61.4M
  • Description
  • Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...
More about CLSD
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.